The pandemic of the novel coronavirus infection has demonstrated to the whole world the necessity of development of screening and preventive examinations as a health care system activity. There are a lot of issues related to the management of patients who underwent COVID-19 despite the large number of studies devoted to the post-COVID-19 syndrome.

OBJECTIVE

To evaluate the effectiveness of detailed screening in early detection of COVID-19 consequences and a number of other chronic non-communicable socially significant diseases.

MATERIAL AND METHODS

The number of patients equal 970 of patients who underwent detailed screening was examined with additional analysis of medical histories during the study. The data of patients’ questionnaires, as well as anthropometric, laboratory and instrumental parameters, noted in the normative documents regulating the I and II stages of detailed screening, were assessed.

RESULTS

The examined 970 patients consisted of 223 (23%) males and 747 (77%) females with an average age equal 52 [39; 64] years. Obesity was registered in 126 (13%) patients. According to the anamnesis, 318 (32.8 %) patients had mild coronavirus infection, 590 (60.8 %) — moderate and 62 (6.4 %) — severe. In most patients, the disease was associated with chronic comorbid pathology, in 38.4% of cases — multimorbid. Average distance of 6-minute walk test was 460 [409; 510] m, 44% of patients had distance of less than 550 m. According to the results of spirometry, 159 (16%) patients had bronchial obstruction, among whom 25% had severe and 13% — extremely severe external respiratory disorders. According to the results of detailed screening, only 164 (16.9%) patients have been established II health group, the majority of patients have been admitted to the outpatient observation and referred to the rehabilitation.

CONCLUSION

The effectiveness of detailed screening in early detection of the post-COVID-19 syndrome and chronic non-communicable diseases was presented.